Trials / Completed
CompletedNCT04994548
Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension
Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension: a Multicenter Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 112 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cirrhotic patients may be at high risk for esophageal cancer. Endoscopic resection is the standard treatment for superficial tumors. However, cirrhosis might be associated with upper gastrointestinal bleeding, particularly in case of portal hypertension or coagulopathy. This study aims to assess safety, efficacy and methods to prevent potential complications in cirrhosis or portal hypertension context for esophageal endoscopic resection. This retrospective multicentric French-Belgian study includes all consecutive patients with cirrhosis or portal hypertension who underwent esophageal endoscopic resection from January 2005 to 2021.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endosocpic resection of early esophageal tumor | under general anesthesia, by mucosectomy or endoscopic submucosal dissection |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2005-02-03
- Completion
- 2021-03-31
- First posted
- 2021-08-06
- Last updated
- 2021-08-06
Source: ClinicalTrials.gov record NCT04994548. Inclusion in this directory is not an endorsement.